Post Time: 2025-02-18
Error: No content files found.A study published in today's online issue of The Lancet finds that patients, who receive statin medications for controlling high-cholesterol, have a slightly greater risk of developing diabetes. However, the study concludes that the potentially small possibility of developing diabetes is outweighed by the benefits gained by lowering the danger of serious heart disease events, such as a heart attack or stroke, in high-risk patients with a history of heart disease. Dr. Antonio M. Gotto, Jr., simply click the up coming post the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College and a world-renowned authority in the field of cardiovascular medicine and statin drug therapies, co-authored the study, which examined data from over 90,000 patients for an average of four years. The findings show that statin therapy was associated with a nine-percent higher risk for diabetes. Interested in learning more about our team of doctors, their patients and how our research is changing lives? Like and subscribe to make sure you never miss out on any of our upcoming videos. secret info Learn more about Dr. Antonio M. Gotto Jr, please visit To learn more about Weill Cornell Medicine patient care please visit here. To learn about education and research at Weill Cornell Medicine visit here. Keep up with our social posts on Facebook Twitter Instagram LinkedIn go here